Octaminomycins A and B, Cyclic Octadepsipeptides Active against Plasmodium falciparum.

Two new cyclic octadepsipeptides, octaminomycins A (1) and B (2), were isolated from a microbial metabolite fraction library of Streptomyces sp. RK85-270 based on Natural Products Plot screening. Their structures were elucidated on the basis of HRESIMS, 1D and 2D NMR spectroscopic data, and MS/MS experiments for sequence analysis. The absolute configurations of the constituent amino acid residues were determined by a combination of single-crystal X-ray diffraction and Marfey's methodology. Notably, octaminomycins A (1) and B (2) showed good in vitro antiplasmodial activity against chloroquine-sensitive as well as chloroquine-resistant strains with no cytotoxicity up to 30 μM.

[1]  Bin-Bin Gu,et al.  New Anti-inflammatory Cyclopeptides From a Sponge-Derived Fungus Aspergillus violaceofuscus , 2018, Front. Chem..

[2]  D. Newman,et al.  Natural Products as Sources of New Drugs from 1981 to 2014. , 2016, Journal of natural products.

[3]  Shunji Takahashi,et al.  Unantimycin A, a new neoantimycin analog isolated from a microbial metabolite fraction library , 2015, The Journal of Antibiotics.

[4]  G. Sheldrick.  SHELXT – Integrated space-group and crystal-structure determination , 2015, Acta crystallographica. Section A, Foundations and advances.

[5]  Shunji Takahashi,et al.  RK-270A−C, new oxindole derivatives isolated from a microbial metabolites fraction library of Streptomyces sp. RK85-270 , 2014, The Journal of Antibiotics.

[6]  A. Batzer,et al.  Antiparasitic chaiyaphumines from entomopathogenic Xenorhabdus sp. PB61.4. , 2014, Journal of natural products.

[7]  Shunji Takahashi,et al.  RK-1355A and B, novel quinomycin derivatives isolated from a microbial metabolites fraction library based on NPPlot screening , 2014, The Journal of Antibiotics.

[8]  David J Newman,et al.  Natural products: a continuing source of novel drug leads. , 2013, Biochimica et biophysica acta.

[9]  Shunji Takahashi,et al.  Pyrrolizilactone, a new pyrrolizidinone metabolite produced by a fungus , 2013, The Journal of Antibiotics.

[10]  K. Tsuge,et al.  Termination of the structural confusion between plipastatin A1 and fengycin IX. , 2012, Bioorganic & medicinal chemistry.

[11]  Shunji Takahashi,et al.  Construction of a microbial natural product library for chemical biology studies. , 2012, Current opinion in chemical biology.

[12]  Shunji Takahashi,et al.  Spirotoamides A and B, novel 6,6-spiroacetal polyketides isolated from a microbial metabolite fraction library , 2011, The Journal of Antibiotics.

[13]  H. Osada,et al.  Systematic isolation of microbial metabolites for natural products depository (NPDepo) , 2011 .

[14]  Jesús Martín,et al.  Current approaches to exploit actinomycetes as a source of novel natural products , 2011, Journal of Industrial Microbiology & Biotechnology.

[15]  Shunji Takahashi,et al.  Verticilactam, a new macrolactam isolated from a microbial metabolite fraction library. , 2010, Organic letters.

[16]  Gregory Kucherov,et al.  NORINE: a database of nonribosomal peptides , 2007, Nucleic Acids Res..

[17]  Roger G. Linington,et al.  Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula. , 2007, Journal of natural products.

[18]  Roger G. Linington,et al.  Venturamides A and B: antimalarial constituents of the panamanian marine Cyanobacterium Oscillatoria sp. , 2007, Journal of natural products.

[19]  Michael A Fischbach,et al.  New antibiotics from bacterial natural products , 2006, Nature Biotechnology.

[20]  Maria Cristina Burla,et al.  SIR2004: an improved tool for crystal structure determination and refinement , 2005 .

[21]  A. Bell,et al.  Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum. , 2003, The Journal of antimicrobial chemotherapy.

[22]  H. Koshino,et al.  Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor. , 1991, The Journal of antibiotics.

[23]  H Osada,et al.  Rapid screening method for inhibitors of protein kinase C. , 1988, The Journal of antibiotics.

[24]  F. Hanaoka,et al.  Screening of cell cycle inhibitors from microbial metabolites by a bioassay using a mouse cdc2 mutant cell line, tsFT210. , 1997, Bioorganic & medicinal chemistry.